WO2022218733A1 - A process for preparation of substituted enamine compounds - Google Patents

A process for preparation of substituted enamine compounds Download PDF

Info

Publication number
WO2022218733A1
WO2022218733A1 PCT/EP2022/058838 EP2022058838W WO2022218733A1 WO 2022218733 A1 WO2022218733 A1 WO 2022218733A1 EP 2022058838 W EP2022058838 W EP 2022058838W WO 2022218733 A1 WO2022218733 A1 WO 2022218733A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
compound
formula
ethyl
dependently
Prior art date
Application number
PCT/EP2022/058838
Other languages
French (fr)
Inventor
Werner Bonrath
Le DAI
Xixiang DAI
Qi Gu
Qiangqiang LIU
Marc-André Mueller
Kun Peng
Liuhai WU
Zili Zhang
Florian ZIEGLER
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Priority to CN202280028180.7A priority Critical patent/CN117177955A/en
Priority to EP22720625.7A priority patent/EP4323332A1/en
Publication of WO2022218733A1 publication Critical patent/WO2022218733A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups

Definitions

  • the present invention is related to a new process for producing substituted enamine compounds.
  • Oxazole compounds represent a vast class of heterocyclic aromatic organic compounds. Oxazole compounds have become increasingly important because of biological activities and their use as intermediates for the preparation of new biological materials.
  • the wide range of biological activities of oxazole compounds includes anti-inflammatory, analgesic, antibacterial, antifungal, hypoglycemic, antiproliferative, anti-tuberculosis, muscle relaxant and HIV inhibitor activity.
  • oxazole derivatives are important intermediates for preparation of biological compounds such as vitamin B 6 .
  • oxazole compounds Various processes for the preparation of oxazole compounds have been developed.
  • One preferred process in industry is from alanine and oxalic acid in EtOH carried out by azeotropic distillation with benzene.
  • the ring closure reaction to obtain 5-ethoxy-4-methyloxazole can also be carried out using phosgene or triphosgene, which is toxic and not environment friendly (see CN 104725262 B, CN 102898321 A and CN 105985297 A)
  • the present invention provides a process for producing a substituted enamine compound of formula (I), which can be converted to an oxazole compound, wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
  • the present invention also provides a process for producing oxazole compounds from the substituted enamine compound of formula (I).
  • the term "lower alkyl” as used refers to Ci-Cio alkyl, i.e., branched or unbranched, cyclic or non-cyclic, saturated hydrocarbon comprising 1-10 carbon atoms.
  • the "lower alkyl” is Ci-C 6 alkyl, including but not limited to methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, tert- butyl, cyclobutyl, pentyl, iso-pentyl, tert-pentyl, cyclopentyl, hexyl, isohexyl, tert-hexyl, cyclohexyl, octyl, isooctyl, tert-octyl, cyclooctyl, nonyl, isononyl, tert-nonyl, cyclon
  • aryl refers to aromatic hydrocarbon such as phenyl, benzyl, xylyl and naphthalenyl.
  • lower alkoxyl refers to the structure represented by (lower alkyl)-0-, wherein the lower alkyl is defined as above.
  • halo or halogen refers to a group of elements including fluorine (F), chlorine (Cl), bromine (Br) and iodine (I), preferably refers to Cl or Br.
  • substituteduents refers to lower alkyl, lower alkoxyl, hydroxyl, halo, -NH 2 , -NO 2 , cyano or isocyano.
  • a compound represented by a formula or a name also cover stereoisomers thereof, including diastereomers and enantiomers, such as cis/trans-isomers or E/Z-isomers.
  • the present invention provides a process for producing a compound of formula (I), comprising: reacting a compound of formula (II) with a compound of formula (III) to produce a compound of formula (I), wherein
  • R is H, lower alkyl or aryl, optionally substituted by one or more substituents
  • R' is hydroxyl, lower alkyl, lower alkoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H or lower alkyl), optionally substituted by one or more substituents.
  • R is H or Ci-C 6 alkyl, optionally substituted by one or more substituents. More preferably, R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents. The most preferably, R is H or methyl.
  • R' is hydroxyl, Ci-C 6 lower alkyl, Ci-C 6 lower alkoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H or Ci-C 6 lower alkyl), optionally substituted by one or more substituents. More preferably, R' is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents.
  • R' is hydroxyl, methoxyl, ethoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H, methyl or ethyl), optionally substituted by one or more substituents.
  • R and R ' are dependently H, methyl or ethyl, optionally substituted by one or more substituents.
  • R is H, methyl, ethyl or phenyl
  • R' is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl).
  • R is H or methyl
  • R' is methoxyl, ethoxyl, -NH 2 , -NHCH 3 , NH(CH 3 ) 2 , NH(CH 2 CH 3 ) 2 , NH(CH 2 CH 2 CH 3 ) 2 or NH(CH 2 CH 2 CH 2 CH 3 ) 2 .
  • the compound of formula (I) and (II) may be in a form of any salt of formula (G) and (IG) respectively: wherein R is defined as above, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), potassium (K), and cesium (Cs)), or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), and barium (Ba)), or Iron (ll/lll); or ammonium (NH ) or substituted ammonium.
  • X and Y are dependently Na or K.
  • the compound of formula (III) is added in an exceed amount.
  • the compound of formula (III) is added in an amount of from 1.0 mols to 20 moles, preferably from 2.0 moles to 18 moles, more preferably from 5.0 mole to 15 moles such as 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0, 12.0, 13.0, 14.0 and 15.0 moles, per 1 mole of the compound of formula (II).
  • the process of the present invention is carried out in the absence of a solvent.
  • the process of the present invention may be carried out in the presence of a solvent.
  • the solvent may be an inorganic solvent such as liquid ammonia, or an organic solvent including but not limited to C5-C12 alkane such as pentane, hexane, heptane, cyclopentane and cyclohexane, aromatic hydrocarbon such as benzene and toluene, ester such as methyl formate and ethyl formate, alcohol such as ethanol, ether such as methyl tert-butyl ether (TBME) and cyclopentyl methyl ether, tertiary amine such as N,N-diethylaniline, triethylamine and tributylamine, amide such as dimethylformamide (DMF), diethylformamide (DEF) and dibutylformamide (DBF), acetonitrile, t
  • the reaction of the present invention may be carried out at the temperature from -50°C to 110°C, preferably from -20°C to 100°C, more preferably from -10°C to 50°C such as -10, -5, 0, 10, 15, 20, 25, 30, 35, 40, 45 and 50°C, under a pressure at 1-20 bar, preferably 2-15 bar, more preferably 3-10 bar such as 3, 4, 5, 6, 7, 8, 9 and 10 bar.
  • the obtained compound of formula (la) may be used to the next step b) directly or purified by known process such as crystallization and/or filtration.
  • the compound of formula (II) may be prepared by any process known in the art in-situ or ex-situ, for example, by treating the compound of formula (lla) with a strong base such as sodium methoxide, sodium ethoxide, sodium hydride (NaFI) and sodium amide.
  • a strong base such as sodium methoxide, sodium ethoxide, sodium hydride (NaFI) and sodium amide.
  • the compound of formula (II) maybe produced from nitriles such as acetonitrile as disclosed in US 5187297 A.
  • the compound of formula (I) according to the present invention can be used for producing oxazole compounds. As a result, the whole process for producing oxazole compounds avoid toxic and unsafe reagents while providing high yield and high selectivity.
  • the present invention provides a process for producing an oxazole compound comprising the step of producing the compound of formula (I) as defined above.
  • the process of the present invention avoids toxic phosphate reagents and saves steps compared to the processes known in the art and thus provides a new process.
  • a dried four necked round bottom flask was charged with liquid ammonia (15 mL, 0.615 mol, 11 eq). After the flask was flushed with argon, sodium (1.5 g, 65 mmol, 1.1 eq) was added and stirred for 30 mins at - 40°C to -50°C. At the same temperature compound 1 (4.85 g, 59 mmol, 1 eq) in THF (20 mL) was added dropwise in 15 mins. Then the reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a white suspension of the compound 2.
  • This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2 (19.40 g, 67.1wt% purity, 97% yield).
  • Example 5 The filter cake obtained according to the same procedures of Example 5 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (100 mL) was added and acetic acid (7.75 g, 129 mmol, 1.0 eq) was added dropwise in 5 mins. The reaction mixture was stirred for 30 mins at room temperature and then filtered over a paper filter (7 cm diameter). The filtrate was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (13.22 g, 98.8wt% purity, 92% yield).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The present invention provides a process for producing a substituted enamine compound of formula (I), and a process for producing oxazole compounds from the compound of formula (I). According to the processes of the present invention, it can produce substituted enamine compounds with high yield and selectivity while avoiding toxic or unsafe reagents for producing oxazole compounds.wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.

Description

A process for preparation of substituted enamine compounds
Technical Field
The present invention is related to a new process for producing substituted enamine compounds.
Background of the Invention
Oxazole compounds represent a vast class of heterocyclic aromatic organic compounds. Oxazole compounds have become increasingly important because of biological activities and their use as intermediates for the preparation of new biological materials. The wide range of biological activities of oxazole compounds includes anti-inflammatory, analgesic, antibacterial, antifungal, hypoglycemic, antiproliferative, anti-tuberculosis, muscle relaxant and HIV inhibitor activity. In addition, oxazole derivatives are important intermediates for preparation of biological compounds such as vitamin B6.
Various processes for the preparation of oxazole compounds have been developed. One preferred process in industry is from alanine and oxalic acid in EtOH carried out by azeotropic distillation with benzene. Following this concept, the ring closure reaction to obtain 5-ethoxy-4-methyloxazole can also be carried out using phosgene or triphosgene, which is toxic and not environment friendly (see CN 104725262 B, CN 102898321 A and CN 105985297 A)
In recent years, one attractive process is direct cyclodehydration of acyloxy enamines because acyloxy enamines have been introduced early N-atom and installed the carboxylic acids. It was reported that acyloxy enamines can be synthesized by intermolecular oxidative coupling of an enamine compound with carboxylic acid by using iodosobenzene as the oxidant. However, oxidant iodosobenzene is highly flammable and has explosion risk. In addition, oxidant iodosobenzene is not soluble in solvents and thus results in unstable yields of the process (see Xin Liu et al., Org. Lett., Vol. 14, No. 21, 2012).
Therefore, there is still demand of a new process for the preparation of substituted enamines, which can be converted to oxazole compounds, in industry.
Summary of the Invention The present invention provides a process for producing a substituted enamine compound of formula (I), which can be converted to an oxazole compound,
Figure imgf000003_0001
wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
The present invention also provides a process for producing oxazole compounds from the substituted enamine compound of formula (I).
According to the processes of the present invention, it can produce substituted enamine compounds with high yield and selectivity, while avoiding toxic or unsafe reagents for producing oxazole compounds.
Detailed Description of the Invention
In the present invention, the term "lower alkyl" as used refers to Ci-Cio alkyl, i.e., branched or unbranched, cyclic or non-cyclic, saturated hydrocarbon comprising 1-10 carbon atoms. Preferably, the "lower alkyl" is Ci-C6 alkyl, including but not limited to methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, tert- butyl, cyclobutyl, pentyl, iso-pentyl, tert-pentyl, cyclopentyl, hexyl, isohexyl, tert-hexyl, cyclohexyl, octyl, isooctyl, tert-octyl, cyclooctyl, nonyl, isononyl, tert-nonyl, cyclononyl, decyl, isodecyl, tert-decyl, cyclodecyl. More preferably, the "lower alkyl" is methyl or ethyl.
In the present invention, the term "aryl" as used refers to aromatic hydrocarbon such as phenyl, benzyl, xylyl and naphthalenyl.
In the present invention, the term "lower alkoxyl" as used refers to the structure represented by (lower alkyl)-0-, wherein the lower alkyl is defined as above.
In the present invention, the term "carbonyl group" as used refers to the structure represented by -(C=0)-. In the present invention, the term "halo" or "halogen" as used refers to a group of elements including fluorine (F), chlorine (Cl), bromine (Br) and iodine (I), preferably refers to Cl or Br.
In the present invention, the term "substituents" as used refers to lower alkyl, lower alkoxyl, hydroxyl, halo, -NH2, -NO2, cyano or isocyano.
In the present invention, a compound represented by a formula or a name also cover stereoisomers thereof, including diastereomers and enantiomers, such as cis/trans-isomers or E/Z-isomers.
In the first aspect of the present invention, it provides a process for producing a compound of formula (I), comprising: reacting a compound of formula (II) with a compound of formula (III) to produce a compound of formula (I),
Figure imgf000004_0001
wherein
R is H, lower alkyl or aryl, optionally substituted by one or more substituents; and
R' is hydroxyl, lower alkyl, lower alkoxyl, or NR4R4' (wherein R and R ' are dependently H or lower alkyl), optionally substituted by one or more substituents.
Preferably, R is H or Ci-C6 alkyl, optionally substituted by one or more substituents. More preferably, R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents. The most preferably, R is H or methyl.
Preferably, R' is hydroxyl, Ci-C6 lower alkyl, Ci-C6 lower alkoxyl, or NR4R4' (wherein R and R ' are dependently H or Ci-C6 lower alkyl), optionally substituted by one or more substituents. More preferably, R' is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents. The most preferably, R' is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl), optionally substituted by one or more substituents. In one embodiment,
R is H, methyl, ethyl or phenyl; and
R' is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl).
In one preferable embodiment,
R is H or methyl; and
R' is methoxyl, ethoxyl, -NH2, -NHCH3, NH(CH3)2, NH(CH2CH3)2, NH(CH2CH2CH3)2 or NH(CH2CH2CH2CH3)2.
In the present invention, the compound of formula (I) and (II) may be in a form of any salt of formula (G) and (IG) respectively:
Figure imgf000005_0001
wherein R is defined as above, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), potassium (K), and cesium (Cs)), or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), and barium (Ba)), or Iron (ll/lll); or ammonium (NH ) or substituted ammonium. Preferably, X and Y are dependently Na or K.
In the process of the present invention, the compound of formula (III) is added in an exceed amount. Preferably, the compound of formula (III) is added in an amount of from 1.0 mols to 20 moles, preferably from 2.0 moles to 18 moles, more preferably from 5.0 mole to 15 moles such as 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0, 12.0, 13.0, 14.0 and 15.0 moles, per 1 mole of the compound of formula (II).
Preferably, the process of the present invention is carried out in the absence of a solvent. Optionally, the process of the present invention may be carried out in the presence of a solvent. The solvent may be an inorganic solvent such as liquid ammonia, or an organic solvent including but not limited to C5-C12 alkane such as pentane, hexane, heptane, cyclopentane and cyclohexane, aromatic hydrocarbon such as benzene and toluene, ester such as methyl formate and ethyl formate, alcohol such as ethanol, ether such as methyl tert-butyl ether (TBME) and cyclopentyl methyl ether, tertiary amine such as N,N-diethylaniline, triethylamine and tributylamine, amide such as dimethylformamide (DMF), diethylformamide (DEF) and dibutylformamide (DBF), acetonitrile, tetrahydrofuran (TH F), 2-methyltetrahydrofuran (MeTFIF), or mixture thereof.
The reaction of the present invention may be carried out at the temperature from -50°C to 110°C, preferably from -20°C to 100°C, more preferably from -10°C to 50°C such as -10, -5, 0, 10, 15, 20, 25, 30, 35, 40, 45 and 50°C, under a pressure at 1-20 bar, preferably 2-15 bar, more preferably 3-10 bar such as 3, 4, 5, 6, 7, 8, 9 and 10 bar. After the reaction finishes, the obtained compound of formula (la) may be used to the next step b) directly or purified by known process such as crystallization and/or filtration.
The compound of formula (II) may be prepared by any process known in the art in-situ or ex-situ, for example, by treating the compound of formula (lla) with a strong base such as sodium methoxide, sodium ethoxide, sodium hydride (NaFI) and sodium amide.
Figure imgf000006_0001
Wherein Ri is as defined above.
Alternatively, the compound of formula (II) maybe produced from nitriles such as acetonitrile as disclosed in US 5187297 A.
The inventor of the present invention surprisingly discovered that the compound of formula (I) according to the present invention is new. Accordingly, in the second aspect of the present invention, it provides a compound of formula (I),
Figure imgf000006_0002
Wherein R is defined as above. As described above, the compound of formula (I) according to the present invention can be used for producing oxazole compounds. As a result, the whole process for producing oxazole compounds avoid toxic and unsafe reagents while providing high yield and high selectivity.
In the third aspect of the present invention, it provides a process for producing an oxazole compound comprising the step of producing the compound of formula (I) as defined above. The process of the present invention avoids toxic phosphate reagents and saves steps compared to the processes known in the art and thus provides a new process.
The present invention will be further illustrated by the following examples.
Examples
Example 1
Figure imgf000007_0001
1 2
A dried four necked round bottom flask was charged with liquid ammonia (15 mL, 0.615 mol, 11 eq). After the flask was flushed with argon, sodium (1.5 g, 65 mmol, 1.1 eq) was added and stirred for 30 mins at - 40°C to -50°C. At the same temperature compound 1 (4.85 g, 59 mmol, 1 eq) in THF (20 mL) was added dropwise in 15 mins. Then the reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a white suspension of the compound 2.
1H NMR of f/Z-isomers of compound 2 (400 MHz, DMSO) d (ppm): 1.74 (3H) (46.7%), 1.53 (3H) (53.3%).
Example 2
Figure imgf000007_0002
2
A dried four necked round bottom flask was charged with liquid ammonia (50 mL, 2.05 mol, 16 eq). After the flask was flushed with argon, iron nitrate nonahydrate (35 mg, 0.087 mmol, 0.00067 eq) was added. Then sodium (2.96 g, 129 mmol, 1.0 eq) was added and stirred for 30 mins at -40°C to -50°C. At the same temperature anhydrous acetonitrile (11.65 g, 283 mmol, 2.2 eq) was added dropwise in 15 mins and anhydrous toluene (40 mL) was added immediately. The reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a grey suspension.
This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2 (19.40 g, 67.1wt% purity, 97% yield).
Example 3
Figure imgf000008_0001
2a
A dried four necked round bottom flask was charged with liquid ammonia (50 mL, 2.05 mol, 18.4 eq). After the flask was flushed with argon, iron nitrate nonahydrate (32 mg, 0.078 mmol, 0.0007 eq) was added. Then, potassium (4.36 g, 112 mmol, 1.0 eq) was added at -50°C and stirred for 30 mins at -40°C to -50°C. At the same temperature anhydrous acetonitrile (10.07 g, 245 mmol, 2.2 eq) was added dropwise in 15 mins and anhydrous acetonitrile (35 mL) was added immediately. The reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a grey suspension.
This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2a (12.56 g, 93% yield).
Example 4
Figure imgf000008_0002
Ethyl formate (2.14 g, 29 mmol, 1.2 eq) was added dropwise to compound 2 (2.50 g, 24 mmol, 1.0 eq) obtained according to the same procedures of Example 2 in 20 min. The reaction mixture was stirred for 1.5 hours to obtain a grey slurry. TBME (30 mL) was added. Then, the mixture was filtrated over a paper filter to obtain a filter cake containing compound 3 (2.60 g, 82% yield). Example 5
Figure imgf000009_0001
Ethyl formate (10.71 g, 142 mmol, 1.1 eq) dissolved in anhydrous toluene (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 in 20 mins. The reaction mixture was stirred overnight to obtain a grey and thick suspension. TBME (100 mL) was added and the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (49.68 g, 31.6wt% purity, 92% yield).
Example 6
Figure imgf000009_0002
Ethyl formate (10.49 g, 142 mmol, 1.1 eq) dissolved in acetonitrile (20 mL) was added dropwise to the grey suspension obtained according to the same procedures of Example 2 (13.43g, 129 mmol, 1.0 eq) in 30 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.84 g, 93% yield).
Example 7
Figure imgf000009_0003
Methyl formate (8.51 g, 142 mmol, 1.1 eq) dissolved in acetonitrile (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 except that toluene was replaced with acetonitrile in 15 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.98 g, 94% yield).
Example 8
Figure imgf000010_0002
Methyl formate (9.28 g, 155 mmol, 1.2 eq) dissolved in TBME (20 mL) was added dropwise to the grey suspension (13.43g, 129 mmol, 1.0 eq) obtained according to the same procedures as Example 2 except that toluene was replaced with TBME (13.43g, 129 mmol, 1.0 eq) in 30 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.19 g, 89% yield).
Example 9
Figure imgf000010_0001
Dimethyl formamide (17.94 g, 245 mmol, 7.7 eq) and the filter cake obtained according to the same procedures of Example 2 (3.3g, 31.7 mmol, 1.0 eq) were placed in the reaction flask. The reaction mixture was stirred for 20 hours at 40°C. TBME (50 mL) was added and the mixture was filtrated over a paper filter (4 cm diameter) to obtain a filter cake containing compound 3 (435 mg, 10% yield).
Example 10
Figure imgf000011_0001
2 3
Dimethyl formamide (6.95 g, 95 mmol, 3 eq) dissolved in toluene (5 mL) was added dropwise to the grey suspension obtained according to the same procedures of Example 2 (3.3g, 31.7 mmol, 1.0 eq) in 10 min. The reaction mixture was stirred for 3 days at 40°Cto obtain a white suspension. TBME (50 mL) was added. Then, the mixture was filtrated over a paper filter (4 cm diameter) to obtain a filter cake containing compound 3 (1.98 g, 47% yield).
Example 11
Figure imgf000011_0002
The filter cake obtained according to the same procedures of Example 5 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (100 mL) was added and acetic acid (7.75 g, 129 mmol, 1.0 eq) was added dropwise in 5 mins. The reaction mixture was stirred for 30 mins at room temperature and then filtered over a paper filter (7 cm diameter). The filtrate was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (13.22 g, 98.8wt% purity, 92% yield).
To a solution of the compound 4 (220 mg, 2.0 mmol) in dried 1,2-dichloroethane (20 mL) was added BF3-Et20 (4.0 mmol). The reaction mixture was heated to reflux, and then phenyliodine(lll) diacetate (838 mg, 2.6 mmol) was added in one portion rapidly. After stirring under reflux for 0.5-3 hours, the reaction mixture was cooled down to room temperature, quenched with saturated aqueous NaHC03, and then extracted with dichloromethane. The combined organic layer was washed with brine, dried over anhydrous l\la2S04 and concentrated by the rotary evaporator. The crude product was purified by flash column chromatography to give the compound 5 with 65% yield.

Claims

Claims
1. A process for producing a compound of formula (I), comprising reacting a compound of formula (II) with a compound of formula (III) to produce a compound of formula (I),
Figure imgf000012_0001
wherein
R is H, lower alkyl or aryl, optionally substituted by one or more substituents; and
R' is hydroxyl, lower alkyl, lower alkoxyl, aryl, or NR R ' (wherein R and R ' are dependently H or lower alkyl), optionally substituted by one or more substituents.
2. The process of claim 1, wherein R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents.
3. The process of claim 1, wherein R' is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents.
4. The process of claim 1, wherein R is H, methyl, ethyl or phenyl; and R' is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl).
5. The process of claim 1, wherein R is H, methyl, ethyl or phenyl; and R' is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl).
6. The process of claim 1, wherein R is H or methyl; and R' is methoxyl, ethoxyl, -NH2, -NHCH3, NH(CH3)2, NH(CH2CH3)2, NH(CH2CH2CH3)2 or NH(CH2CH2CH2CH3)2.
7. The process of claim 1, wherein the compound of formula (I) and (II) are in a form of any salt of formula (G) and (IG) respectively:
Figure imgf000013_0001
(I ) (II ) wherein R is defined as any one of claims 1-6, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), potassium (K), and cesium (Cs)), or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), and barium (Ba)), or Iron (ll/lll); or ammonium (NH ) or substituted ammonium.
8. The process of any one of claims 1-7, wherein the step a) of the process is carried out in the absence of a solvent.
9. The process of any one of claims 1-7, wherein the step a) of the process is carried out in the presence of a solvent.
10. The process of claim 9, wherein the solvent is an inorganic solvent such as liquid ammonia, or an organic solvent including but not limited to
Figure imgf000013_0002
alkane such as pentane, hexane, heptane, cyclopentane and cyclohexane, aromatic hydrocarbon such as benzene and toluene, ester such as methyl formate and ethyl formate, alcohol such as ethanol, ether such as methyl tert-butyl ether (TBME) and cyclopentyl methyl ether, tertiary amine such as N,N-diethylaniline, triethylamine and tributylamine, amide such as dimethylformamide (DMF), diethylformamide (DEF) and dibutylformamide (DBF), acetonitrile, tetrahydrofuran (THF), 2-methyltetrahydrofuran (MeTHF), or mixture thereof.
11. A process for producing an oxazole compound comprising the step of producing the compound of formula (I) according to any one of claims 1-10.
PCT/EP2022/058838 2021-04-15 2022-04-04 A process for preparation of substituted enamine compounds WO2022218733A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202280028180.7A CN117177955A (en) 2021-04-15 2022-04-04 Process for preparing substituted enamine compounds
EP22720625.7A EP4323332A1 (en) 2021-04-15 2022-04-04 A process for preparation of substituted enamine compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/087510 2021-04-15
CN2021087510 2021-04-15

Publications (1)

Publication Number Publication Date
WO2022218733A1 true WO2022218733A1 (en) 2022-10-20

Family

ID=81579511

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2022/058838 WO2022218733A1 (en) 2021-04-15 2022-04-04 A process for preparation of substituted enamine compounds

Country Status (3)

Country Link
EP (1) EP4323332A1 (en)
CN (1) CN117177955A (en)
WO (1) WO2022218733A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484855A2 (en) * 1990-11-05 1992-05-13 Lonza Ag Process for the preparation of 3-aminocrotonitrile
CN102898321A (en) 2011-07-24 2013-01-30 上海海嘉诺医药发展股份有限公司 Method for preparing N-butoxy oxalyl butyl alaninate
CN104725262A (en) 2013-12-23 2015-06-24 大丰海嘉诺药业有限公司 Method for continuously preparing N-ethyloxyl oxalyl alanine ethyl ester
CN105985297A (en) 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl
CN111848449A (en) * 2019-04-30 2020-10-30 帝斯曼知识产权资产管理有限公司 Novel acyloxy enamine compound
WO2021209269A1 (en) * 2020-04-17 2021-10-21 Dsm Ip Assets B.V. A process for preparation of substituted enamine compounds

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484855A2 (en) * 1990-11-05 1992-05-13 Lonza Ag Process for the preparation of 3-aminocrotonitrile
US5187297A (en) 1990-11-05 1993-02-16 Lonza Ltd. Process for the production of 3-aminocrotononitrile
CN102898321A (en) 2011-07-24 2013-01-30 上海海嘉诺医药发展股份有限公司 Method for preparing N-butoxy oxalyl butyl alaninate
CN104725262A (en) 2013-12-23 2015-06-24 大丰海嘉诺药业有限公司 Method for continuously preparing N-ethyloxyl oxalyl alanine ethyl ester
CN105985297A (en) 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl
CN111848449A (en) * 2019-04-30 2020-10-30 帝斯曼知识产权资产管理有限公司 Novel acyloxy enamine compound
WO2021209269A1 (en) * 2020-04-17 2021-10-21 Dsm Ip Assets B.V. A process for preparation of substituted enamine compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIU XIN ET AL, vol. 14, no. 21, 2 November 2012 (2012-11-02), US, pages 5480 - 5483, XP055837609, ISSN: 1523-7060, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/ol3025583> DOI: 10.1021/ol3025583 *
MEYER E V: "Untersuchungen aus dem organ.-chem. Laboratorium der Technicschne Hochschule zu Dresden: CVI. Neue Beiträge zur Kenntnis der di-molekulären Nitrile", vol. 90, no. 1, 12 June 1914 (1914-06-12), pages 1 - 52, XP009035294, ISSN: 0021-8383, Retrieved from the Internet <URL:https://gallica.bnf.fr/ark:/12148/bpt6k90862k/f61.item> [retrieved on 20041119], DOI: 10.1002/PRAC.19140900101 *
XIN LIU ET AL., ORG. LETT., vol. 14, no. 21, 2012

Also Published As

Publication number Publication date
CN117177955A (en) 2023-12-05
EP4323332A1 (en) 2024-02-21

Similar Documents

Publication Publication Date Title
JP2024023340A (en) Preparation method of glufosinate ammonium
HU225294B1 (en) Oxazoline derivatives for synthesis of sidechain-bearing taxanes and preparation thereof
EP2189442B1 (en) Process and intermediates for the preparation of aliskiren
EP4136066A1 (en) A process for preparation of substituted enamine compounds
KR20020033617A (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
KR100980379B1 (en) Process for the preparation of optically active 5-hydroxy-3-oxoheptanoate derivatives
WO2022218733A1 (en) A process for preparation of substituted enamine compounds
WO2020094434A1 (en) Process for preparation of optically enriched isoxazolines
WO2022218734A1 (en) A process for preparation of substituted enamine compounds
AU777959B2 (en) Process for preparing quinolylacrylonitrile and intermediates therefor
US6414180B1 (en) Synthesis of chiral β-amino acids
US6329536B1 (en) Stereoselective process for producing nitro compounds
CN111556861A (en) Preparation method of jasmonate compound
US20100076199A1 (en) Process for the preparation of substituted pyridone carboxylic acids
KR19990008411A (en) Improvement method of 4-hydroxy-2-pyrrolidone
CA2998438A1 (en) New process and intermediates for preparing sacubitril or derivatives thereof
US7078543B2 (en) Methods for producing oxirane carboxylic acids and derivatives thereof
CN112135820B (en) Novel process for preparing diaminopyrimidine derivatives or acid addition salts thereof
KR102060318B1 (en) Novel intermediate, processes for preparing the same, and processes for preparing rosuvastatin calcium salt using the same
DE102007049039A1 (en) Process for the preparation of 8-hydrazino-8-aryl-octanoyl derivatives and their use
JP7128629B2 (en) Method for producing lubiprostone
JP4561635B2 (en) Process for producing 4-alkoxycarbonyltetrahydropyran or tetrahydropyranyl-4-carboxylic acid
JP4929717B2 (en) Process for producing N, N&#39;-dialkoxy-N, N&#39;-dialkyloxamide
JPS5813547B2 (en) Cinquinapiride (2,3-D) Pyrimidinedione
JP3283959B2 (en) D-biotin intermediate and method for producing the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22720625

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2022720625

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022720625

Country of ref document: EP

Effective date: 20231115